Suchergebnisse - "Perrone, Francesco"

PubPharm (403)

91

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer : Joint Analysis of MILES-3 and MILES-4 Phase III Trials

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Gridelli, C. | Morabito, A. | Cavanna, L. | +27

CommentIn: J Clin Oncol. 2018 Sep 1;36(25):2571-2574. - PMID 30028655

92

Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study

enthalten in: Endocrine | 2018

von Chiofalo, M. | Signoriello, S. | Fulciniti, F. | +16

93

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3) : a randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2018

von De Placido, S. | Gallo, C. | De Laurentiis, M. | +128

CommentIn: Lancet Oncol. 2018 Apr;19(4):431-432. - PMID 29482984

94

Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study

enthalten in: Endocrine | 2018

von Chiofalo, M. | Signoriello, S. | Fulciniti, F. | +16

95

Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study

enthalten in: Endocrine | 2018

von Chiofalo, M. | Signoriello, S. | Fulciniti, F. | +16

96

Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study

enthalten in: Endocrine | 2018

von Chiofalo, M. | Signoriello, S. | Fulciniti, F. | +16

97

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer : The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Pignata, S. | Scambia, G. | Bologna, A. | +25

98

Angiogenesis Inhibitors in NSCLC

enthalten in: International journal of molecular sciences | 2017

von Manzo, A. | Montanino, A. | Carillio, G. | +8

99

Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients

enthalten in: Oncotarget | 2017

von Kim, L. | Saieg, M. | Di Maio, M. | +17

100

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients : The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2017

von Morabito, A. | Daniele, G. | Costanzo, R. | +17